Water level changes in the Caspian Sea. by Zihao Duan (17403792)

Subjects:

Methods used to extract shoreline changes. by Zihao Duan (17403792)

Subjects:

Coastline variations in different years. Map data were generated with Natural Earth (http://www.naturalearthdata.com/). by Zihao Duan (17403792)

Subjects:

Study area of the Caspian Sea. by Zihao Duan (17403792)

Subjects:

Morlet wavelet power spectrum of the sea level. by Zihao Duan (17403792)

Subjects:

(a) Change rates were calculated for each transect along the coastlines from 1985 to 2023; (b) Coastline change rates of the Caspian Sea based on the EPR and LRR. by Zihao Duan (17403792)

Subjects:

Water surface transitions from 1984 to 2021. The map data were generated by the Global Surface Water Explorer (https://global-surface-water.appspot.com/faq). by Zihao Duan (17403792)

Subjects:

The coastline changes of the Aral Sea from 1960 to 2023. Land cover data are from LANDSAT 8 ( by Zihao Duan (17403792)

Subjects:

Coastal area changes during the period 1985–2023. by Zihao Duan (17403792)

Subjects:

(a) Surface area and volume change with water level; (b) Topographic changes in the Caspian Sea. by Zihao Duan (17403792)

Subjects:

(a) Coastline length changes in the Caspian Sea; (b) LSI changes between 1985 and 2023 (P1 = 1985–1990, P2 = 1990–1995, P3 = 1995–2000, P4 = 2000–2005, P5 = 2005–2010, P6 = 2010–20... by Zihao Duan (17403792)

Subjects:

Data Sheet 1_Case Report: Personalized peptide-based immunization in an advanced-stage prostate cancer patient with bone metastasis.docx by Nils Heinrich Thoennissen (21758162)

“…<p>Neoantigens, which are recognized as non-self and trigger an immune response, are novel antigens generated by tumor cells. Here, we report a de novo metastatic hormone-sensitive prostate cancer (mHSPC) case, which benefited from our personalized peptide immunization named BioInformatic Tumor Address Peptides (BITAP) in a monotherapeutic setting. …”

Table 1_Diffuse panbronchiolitis as a rare complication of thymectomy and radiation therapy in a patient with thymoma: a case report.docx by Ye Lu (138787)

Flowchart of the screening process. by Huixia Ren (500186)

“…The PRISMA, AMSTAR-2, and ROBIS tools were used to assess reporting quality, methodological quality, and risk of bias, respectively.…”

Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…The PRISMA, AMSTAR-2, and ROBIS tools were used to assess reporting quality, methodological quality, and risk of bias, respectively.…”

Characteristics of included reviews. by Huixia Ren (500186)

“…The PRISMA, AMSTAR-2, and ROBIS tools were used to assess reporting quality, methodological quality, and risk of bias, respectively.…”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…The PRISMA, AMSTAR-2, and ROBIS tools were used to assess reporting quality, methodological quality, and risk of bias, respectively.…”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…The PRISMA, AMSTAR-2, and ROBIS tools were used to assess reporting quality, methodological quality, and risk of bias, respectively.…”

Boxplots of different epigenetic age acceleration measures in breast cancer cases (orange) and disease-free controls (pink). by Yanning Wu (465741)

Subjects:

The ROR of the top 50 AE reports in children. by Yanmo Yang (22766389)

“…Notably, 25.5% of reported AEs required hospitalization, while fatal and life-threatening outcomes accounted for 0.9% and 1.4% of cases, respectively. …”